Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 28 Article 3
Back to Table of Contents
Previous
Next

Eurosurveillance, Volume 7, Issue 28, 10 July 2003
Articles

Citation style for this article: Human monkeypox in the US: investigations confirm that multiple animal species are susceptible to infection. Euro Surveill. 2003;7(28):pii=2255. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2255

Human monkeypox in the US: investigations confirm that multiple animal species are susceptible to infection

Editorial team (eurowkly@hpa.org.uk), Eurosurveillance editorial office.

Traceback investigations in the human monkeypox outbreak in the United States have implicated a shipment of animals from Ghana, imported to Texas on 9 April, as the probable source of introduction of monkeypox virus into the US (1). The shipment contained approximately 800 small mammals of nine different species, including six genera of African rodents. Gambian rats from this shipment were kept in close proximity to prairie dogs at an Illinois animal vendor implicated in the sale of infected prairie dogs.

The Centers for Disease Control and Prevention (CDC) in the US has confirmed the presence of monkeypox virus in one Gambian giant rat, three dormice, and two rope squirrels that were part of the 9 April shipment (2). Evaluation of other animals associated with the shipment is ongoing. Evidence of infection was found in some animals that had been separated from the rest of the shipment on the day of their arrival into the US, indicating early and possibly widespread infection among the remaining animals in the shipment. The laboratory investigation confirmed that multiple animal species are susceptible to infection with monkeypox virus (1).

Twenty eight residents of six states have received smallpox vaccine since 13 June, to prevent further spread of monkeypox (1). Up to date information on the outbreak is available at http://www.cdc.gov/ncidod/monkeypox/index.htm.

References :
  1. CDC. Update: Multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52(Dispatch); 1-3. (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm52d702a1.htm)
  2. Eurosurveillance Weekly. Source of US monkeypox outbreak of identified, and CDC issues updated interim guidance for prevention and treatment of monkeypox. Eurosurveillance Weekly 2003; 7: 030703. (http://www.eurosurveillance.org/ew/2003/030703.asp)

back to top



Back to Table of Contents
Previous
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.